Share of people with HIV who receive antiretroviral therapy in Sweden
Sweden: Share of people with HIV who receive antiretroviral therapy was 95.0% in 2022. ▲ Rising
Share of people with HIV who receive antiretroviral therapy in Sweden, 2000–2022
Source: UNAIDS estimates, via World Bank (2026) – processed by Our World in Data. Measured in % of people living with HIV.
Analysis
Sweden recorded 95.0% for share of people with hiv who receive antiretroviral therapy in 2022.
Compared with earlier readings it is up 10.5% over ten years.
Over the whole period, share of people with hiv who receive antiretroviral therapy in Sweden peaked at 97.0% in 2017 and was at its lowest, 31.0%, in 2000.
Sweden ranks 3rd of 143 countries on this measure, in the top 10%.
The long-run direction has been consistently rising across the 23 years of available data.
Share of people with HIV who receive antiretroviral therapy in Sweden, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 31.0% | — |
| 2001 | 33.0% | +6.5% |
| 2002 | 34.0% | +3.0% |
| 2003 | 43.0% | +26.5% |
| 2004 | 46.0% | +7.0% |
| 2005 | 48.0% | +4.3% |
| 2006 | 50.0% | +4.2% |
| 2007 | 59.0% | +18.0% |
| 2008 | 70.0% | +18.6% |
| 2009 | 76.0% | +8.6% |
| 2010 | 81.0% | +6.6% |
| 2011 | 83.0% | +2.5% |
| 2012 | 86.0% | +3.6% |
| 2013 | 90.0% | +4.7% |
| 2014 | 93.0% | +3.3% |
| 2015 | 95.0% | +2.2% |
| 2016 | 96.0% | +1.1% |
| 2017 | 97.0% | +1.0% |
| 2018 | 97.0% | +0.0% |
| 2019 | 97.0% | +0.0% |
| 2020 | 96.0% | -1.0% |
| 2021 | 95.0% | -1.0% |
| 2022 | 95.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 49.0% | 31.0% | 76.0% | 10 |
| 2010s | 91.5% | 81.0% | 97.0% | 10 |
| 2020s | 95.3% | 95.0% | 96.0% | 3 |
Countries ranked near Sweden
More health data for Sweden
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.8581 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,109 deaths per 1,000 people (2090)
- Number of infants who die before age 1 30 deaths (2100)
- Population ages 65-69, male, annual growth rate 0.5396 % change on previous year (2025)
- Population ages 65-69, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65-69, male, per capita 0.0257 units per person (2025)
- Population ages 70-74, female, annual growth rate -1.08 % change on previous year (2025)
- Population ages 70-74, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 70-74, female, per capita 0.0245 units per person (2025)
Frequently asked questions
- What is share of people with hiv who receive antiretroviral therapy in Sweden?
- Share of people with hiv who receive antiretroviral therapy in Sweden was 95.0% in 2022, according to UNAIDS estimates, via World Bank (2026) – processed by Our World in Data.
- What is the highest share of people with hiv who receive antiretroviral therapy recorded in Sweden?
- The highest recorded value was 97.0% in 2017.
- What is the lowest share of people with hiv who receive antiretroviral therapy recorded in Sweden?
- The lowest recorded value was 31.0% in 2000.
- How does Sweden rank for share of people with hiv who receive antiretroviral therapy?
- Sweden ranks 3rd out of 143 countries with data for 2022.
- Is share of people with hiv who receive antiretroviral therapy rising or falling in Sweden?
- Over the last ten years it is up 10.5%. The long-run trend across the full record is rising.
- Where does this Sweden data come from?
- The figures come from UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as part of Share of people with HIV who receive antiretroviral therapy. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 23 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.